Vanguard Personalized Indexing Management, LLC Cure Vac N.V. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.46 Billion
- Q4 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 10,358 shares of CVAC stock, worth $37,806. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,358
Previous 37,941
72.7%
Holding current value
$37,806
Previous $111,000
68.47%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CVAC
# of Institutions
86Shares Held
12.6MCall Options Held
68.1KPut Options Held
55.7K-
Black Rock Inc. New York, NY2.25MShares$8.23 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.65MShares$6.01 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$5.73 Million10.6% of portfolio
-
Ubs Group Ag577KShares$2.11 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$1.83 Million0.01% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $684M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...